Ретровир

Ретровир (Zidovudine) is an antiretroviral medication used in combination therapy for HIV management. This nucleoside reverse transcriptase inhibitor helps reduce viral load and supports immune function. Suitable for adults and children, it is available in oral and intravenous forms. Consult healthcare providers for personalized guidance.

Zidovudine is primarily used to treat HIV infection, helping to control the virus and slow disease progression. It is often prescribed as part of a combination regimen for adults and children. The medication works by blocking the reverse transcriptase enzyme, which HIV needs to multiply. It may also be used to prevent mother-to-child transmission of HIV during pregnancy and labor.

Zidovudine helps reduce the amount of HIV in the body, supporting immune system health over time. Users may notice improved energy levels and reduced frequency of infections as the medication takes effect. Regular monitoring is recommended to assess its ongoing effectiveness and safety.

Store zidovudine at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use if the packaging is damaged or the liquid appears discolored. Inform your healthcare provider about any existing medical conditions or allergies before starting treatment.

Zidovudine may interact with other medications, including certain antibiotics, antifungals, and drugs affecting the liver. Alcohol and herbal supplements, such as St. John’s wort, can also influence its effects. Always disclose all medications and supplements to your healthcare provider to avoid potential interactions.